Ordering
Available Variants10 mg
CHA.69505-10mg
Price
€120.00
Available – Dispatch in 14 days
50 mg
CHA.69505-50mg
Price
€440.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.69505-10mg | €120.00 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.69505-50mg | €440.80 |
≥98% (HPLC), translation elongation inhibitor, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C29H39NO9 |
|---|---|
| CAS Number | 26833-87-4 |
| Molecular Weight | 545.62 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 329825468 |
| NACRES | NA.77 |
| MDL number | MFCD03410264 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| pictograms |
GHS06
 GHS06
|
|---|---|
| signalword | Danger |
| hcodes | H300 + H310 + H330 |
| pcodes | P260 - P262 - P264 - P280 - P302 + P352 + P310 - P304 + P340 + P310 |
| Hazard Classifications | Acute Tox. 2 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral |
| Storage Class | 6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Homoharringtonine, also known as omacetaxine mepesuccinate, is a cephalotaxine ester with a chemical formula of C34H46N4O10 and a molecular weight of 670.74 g/mol. Its CAS number is 26833-87-4. This compound is a naturally occurring alkaloid derived from the genus Cephalotaxus, with notable antineoplastic and antileukemic properties. Homoharringtonine functions by inhibiting protein synthesis, which leads to the induction of apoptosis in cancer cells. It has been primarily investigated for its potential in treating various types of leukemia, including chronic myeloid leukemia and acute myeloid leukemia. The mechanism of action involves binding to the ribosomal A-site cleft, thereby interfering with the initiation complex of peptide formation and ultimately resulting in the inhibition of protein synthesis. This unique mechanism of action makes homoharringtonine an attractive candidate for further research and development in oncology.
